ACADIA PHARMACEUTICALS INC — Director's Dealing 2018

Nov 9, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ACADIA PHARMACEUTICALS INC (ACAD)
CIK: 0001070494
Period of Report: 2018-11-02

Reporting Person: Miller Eric Alejandro (Controller & PAO)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3212	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (Right to Buy)	$20.65	2024-05-29	Common Stock (7500)		Direct
Employee Stock Option (Right to Buy)	$32.28	2025-01-25	Common Stock (3900)		Direct
Employee Stock Option (Right to Buy)	$29.24	2026-01-05	Common Stock (6615)		Direct
Employee Stock Option (Right to Buy)	$36.54	2027-03-07	Common Stock (7350)		Direct
Employee Stock Option (Right to Buy)	$35.80	2027-09-06	Common Stock (9187)		Direct
Employee Stock Option (Right to Buy)	$16.50	2028-04-06	Common Stock (5570)		Direct
Employee Stock Option (Right to Buy)	$21.28	2028-10-14	Common Stock (3342)		Direct
Restricted Stock Units	$		Common Stock (1671)		Direct

Footnotes

F1: This option is fully vested and exercisable.

F2: 25% of the shares subject to the Stock Option vested and became exercisable on January 1, 2016, and the remaining shares vest and become exercisable in 36 equal monthly installments thereafter.

F3: 25% of the shares subject to the Stock Option vested and became exercisable on January 1, 2017, and the remaining shares vest and become exercisable in 36 equal monthly installments thereafter.

F4: 25% of the shares subject to the Stock Option vested and became exercisable on March 8, 2018, and the remaining shares vest and become exercisable in 36 equal monthly installments thereafter.

F5: 25% of the shares subject to the Stock Option vested and became exercisable on September 7, 2018, and the remaining shares vest and become exercisable in 36 equal monthly installments thereafter.

F6: 25% of the shares subject to the Stock Option vest and become exercisable on April 7, 2019, and the remaining shares vest and become exercisable in 36 equal monthly installments thereafter.

F7: 25% of the shares subject to the Stock Option vest and become exercisable on October 15, 2019, and the remaining shares vest and become exercisable in 36 equal monthly installments thereafter.

F8: The restricted stock units vest in four equal annual installments beginning October 15, 2019.

F9: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.